Efficacy of three alternative hepatitis B revaccination series (Fendrix®, Twinrix® and HBVaxPro‐40®) in healthy non‐responders; an open‐label, randomised controlled multicentre trial
HomePresentaties & PostersEfficacy of three alternative hepatitis B revaccination series (Fendrix®, Twinrix® and HBVaxPro‐40®) in healthy non‐responders; an open‐label, randomised controlled multicentre trial